HERTFORDSHIRE, England, BANGALORE, India and PITTSBURGH, Nov. 20, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that its subsidiary, Mylan Laboratories Limited, has successfully completed the acquisition of certain women's healthcare businesses, now known as Jai Pharma, which were spun off from Famy Care Limited. The transaction brings Mylan a broad women's care portfolio, strong technical capabilities and dedicated hormone manufacturing, which, when combined with Mylan's expansive global commercial footprint and supply chain infrastructure, will create a leading women's healthcare franchise. Mylan CEO Heather Bresch commented, "The completion of this transaction...
↧